Articles

Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study

Department of Hematology, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea
Department of Hematology, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea
Department of Hematology, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea
Department of Hematology, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea
Department of Hematology, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea
Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea
Department of Hematology-Oncology, Chonnam National University Hwasun, Hospital, Busan, Korea
Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea
Department of Internal Medicine, Hallym University College of Medicine, Anyang, Korea
Division of Hematology-Oncology, Department of Internal Medicine, Kangbuk Samsung Hospital, School of Medicine, Sungkyunkwan University, Seoul, Korea
Division of Hematology and Cellular Therapy, Ulsan University Hospital, University of Ulsan College of Medicine, Daegu, Korea
Division of Hematology-Oncology, School of Medicine, Keimyung University, Daegu, Korea
Division of Hematology-Oncology, Chonbuk National University Medical School, Jeonju, Korea
Department of Hematology, St. Vincent’s Hospital, The Catholic University of Korea, Suwon, Korea
Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Department of Hematology, School of Medicine, Ewha Womans University, Seoul, Korea
Department of Internal Medicine, Inje University College of Medicine, Inje University Busan Paik Hospital, Ilsan, Korea
Department of Hematology-Oncology, National Health Insurance Service Ilsan Hospital, Ilsan, Korea
Department of Hematology, Gachon University Gil Hospital, Incheon, Korea
Department of Hematology-Oncology, Chungbuk National University Hospital, Cheongju, Korea
Department of Hematology, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea;Catholic Leukemia Research Institute, The Catholic University of Korea, Seoul, Korea
Vol. 101 No. 6 (2016): June, 2016 https://doi.org/10.3324/haematol.2015.139899